Cas:13757-97-6 5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol manufacturer & supplier

We serve Chemical Name:5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol CAS:13757-97-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol

Chemical Name:5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol
CAS.NO:13757-97-6
Synonyms:2(1H)-Quinolinone,5-(2-amino-1-hydroxyethyl)-3,4-dihydro-8-hydroxy;(R*,S*)-(+)-8-hydroxy-5-[1-hydroxy-2-[(1-methylethyl)amino]butyl]-2(1H)-quinolinone;(+/-)-Quinterenol;5-(2-amino-1-hydroxy-ethyl)-8-hydroxy-3,4-dihydro-1H-quinolin-2-one;5-(1-Hydroxy-2-amino)ethyl-8-hydroxy-3,4-dihydrocarbostyril;5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril;5-(1-hydroxy-2-isopropylamino-ethyl)-quinolin-8-ol;8-hydroxy-5-(1-hydroxy-2-isopropylamino-butyl)-1H-quinolin-2-one;erythro-8-hydroxy-5-[1-hydroxy-2-(isopropylamino)-butyl]carbostyril
Molecular Formula:C14H18N2O2
Molecular Weight:246.30500
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:462.3ºC at 760mmHg
Density:1.201g/cm3
Index of Refraction:1.626
PSA:65.38000
Exact Mass:246.13700
LogP:2.36270

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2(1H)-Quinolinone,5-(2-amino-1-hydroxyethyl)-3,4-dihydro-8-hydroxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,erythro-8-hydroxy-5-[1-hydroxy-2-(isopropylamino)-butyl]carbostyril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(1-hydroxy-2-isopropylamino-ethyl)-quinolin-8-ol Use and application,2(1H)-Quinolinone,5-(2-amino-1-hydroxyethyl)-3,4-dihydro-8-hydroxy technical grade,usp/ep/jp grade.


Related News: The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). ethyl (E)-2-methyl-3-(1-((pivaloyloxy)methyl)-4-(pyridin-4-yl)-1H-pyrrol-2-yl)acrylate manufacturers He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility. 1-[(1-Hydroxy-2-methoxycarbonylaminonaphthalen-5-ylcarbamoyl)methyl]pyridinium chloride suppliers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. 2-acetylcyclopentane-1,3-dione vendor & factory.